Senior insider sale
CRINETICS PHARMACEUTICALS, INC. — senior position signals high conviction
$241.5K
6.90K shares
What this filing means
OKEY STEPHANIE plans to sell 6.90K shares of CRINETICS PHARMACEUTICALS, INC. valued at approximately $241.5K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/17/2026ACC: 0001950047-26-006257
Director
Since Jul 2019
6.90K
Shares to sell
$241.5K
Approx. market value
6.90K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Units
N/A
6/11/2026
6.90KTotal acquired6.90K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/11/2026 | Restricted Stock Units N/A | 6.90K | — |
| Total | 6.90K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
6.90K
Market value
$241.5K
6/17/2026
Total
Units
6.90K
Value
$241.5K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
6/17/2026 | 6.90K | $241.5K | NASDAQ | Planned |
| Total | 6.90K | $241.5K | ||